Evidence map›Paper›PMID 38584468›Full record

Trial reportEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2024

First-in-human clinical series of a novel conformable large-lattice pulsed field ablation catheter for pulmonary vein isolation.

Vivek Y Reddy, Elad Anter, Petr Peichl, Gediminas Rackauskas, Jan Petru, Moritoshi Funasako, Jacob S Koruth, Germanas Marinskis, Mohit Turagam, Audrius Aidietis and 3 more

2 registry-linked trialsAbstract readMulticenter StudyClinical Trial
In one paragraph

Trial report in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05115214 narecruitingnot on this map

A Safety and Performance Assessment of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation

TypeinterventionalSponsorMedtronic Cardiac Ablation SolutionsRan2021 to 2027Enrolled150ConditionsAtrial FibrillationArmsSpherePVI™ Catheter
NCT05144503 narecruitingnot on this map

A Safety and Performance Assessment of the SpherePVI™ Catheter and the Affera Mapping and Ablation System to Treat Paroxysmal Atrial Fibrillation

TypeinterventionalSponsorMedtronic Cardiac Ablation SolutionsRan2021 to 2027Enrolled100ConditionsAtrial FibrillationArmsSpherePVI™ Catheter
3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Efficacy and safety of a novel pulsed field ablation system in paroxysmal atrial fibrillation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Pulsed-field ablation beyond pulmonary vein for persistent atrial fibrillation: efficacy and impact on left atrial function.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  14. Review
  15. Review
  16. Review
  17. General anaesthesia and deep sedation for monopolar pulsed field ablation using a lattice-tip catheter combined with a novel three-dimensional mapping system.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  18. Application repetition and electrode-tissue contact result in deeper lesions using a pulsed-field ablation circular variable loop catheter.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  19. A large footprint focal catheter toggling between pulsed field and radiofrequency energy: first clinical experience for ventricular tachycardia ablation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Vivek Y ReddyDepartment of Cardiology, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, Box 1030, New York, NY, USA.ORCID 0000-0002-5638-4993
Elad AnterDivision of Cardiovascular Medicine, Shamir Medical Center, Be'er Yaakov, Tel Aviv, Israel.ORCID 0000-0002-8199-2288
Petr PeichlDepartment of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic.ORCID 0000-0002-5625-0071
Gediminas RackauskasDepartment of Cardiology, Vilnius University, Vilnius, Lithuania.ORCID 0000-0003-3272-4380
Jan PetruDepartment of Cardiology, Homolka Hospital, Prague, Czech Republic.
Moritoshi FunasakoDepartment of Cardiology, Homolka Hospital, Prague, Czech Republic.ORCID 0000-0002-1620-3924
Jacob S KoruthDepartment of Cardiology, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, Box 1030, New York, NY, USA.ORCID 0000-0002-2221-8372
Germanas MarinskisDepartment of Cardiology, Vilnius University, Vilnius, Lithuania.
Mohit TuragamDepartment of Cardiology, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, Box 1030, New York, NY, USA.
Audrius AidietisDepartment of Cardiology, Vilnius University, Vilnius, Lithuania.
Josef KautznerDepartment of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic.ORCID 0000-0002-1632-6182
Andrea NataleTexas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX, USA.ORCID 0000-0001-6601-944X
Petr NeuzilDepartment of Cardiology, Homolka Hospital, Prague, Czech Republic.ORCID 0000-0003-4334-8165

Funding

Affera, Inc
6 · The paper itself

Abstract

aimsPulsed field ablation (PFA) has significant advantages over conventional thermal ablation of atrial fibrillation (AF). This first-in-human, single-arm trial to treat paroxysmal AF (PAF) assessed the efficiency, safety, pulmonary vein isolation (PVI) durability and one-year clinical effectiveness of an 8 Fr, large-lattice, conformable single-shot PFA catheter together with a dedicated electroanatomical mapping system. METHODS AND

resultsAfter rendering the PV anatomy, the PFA catheter delivered monopolar, biphasic pulse trains (5-6 s per application; ∼4 applications per PV). Three waveforms were tested: PULSE1, PULSE2, and PULSE3. Follow-up included ECGs, Holters at 6 and 12 months, and symptomatic and scheduled transtelephonic monitoring. The primary and secondary efficacy endpoints were acute PVI and post-blanking atrial arrhythmia recurrence, respectively. Invasive remapping was conducted ∼75 days post-ablation. At three centres, PVI was performed by five operators in 85 patients using PULSE1 (n = 30), PULSE2 (n = 20), and PULSE3 (n = 35). Acute PVI was achieved in 100% of PVs using 3.9 ± 1.4 PFA applications per PV. Overall procedure, transpired ablation, PFA catheter dwell and fluoroscopy times were 56.5 ± 21.6, 10.0 ± 6.0, 19.1 ± 9.3, and 5.7 ± 3.9 min, respectively. No pre-defined primary safety events occurred. Upon remapping, PVI durability was 90% and 99% on a per-vein basis for the total and PULSE3 cohort, respectively. The Kaplan-Meier estimate of one-year freedom from atrial arrhythmias was 81.8% (95% CI 70.2-89.2%) for the total, and 100% (95% CI 80.6-100%) for the PULSE3 cohort.

conclusionPulmonary vein isolation (PVI) utilizing a conformable single-shot PFA catheter to treat PAF was efficient, safe, and effective, with durable lesions demonstrated upon remapping.

Indexed as

Atrial FibrillationCardiac CathetersCatheter AblationPulmonary VeinsRecurrenceAction PotentialsAgedElectrophysiologic Techniques, CardiacEquipment DesignFemaleHeart RateHumansMaleMiddle AgedTime FactorsTreatment OutcomeAtrial fibrillationCatheter ablationElectroanatomical mapping systemLesion durabilityPulsed field ablationSingle-shot

Identifiers

PMID38584468
PMCPMC11057205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.